Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-26-000715
Filing Date
2026-01-08
Accepted
2026-01-08 16:05:40
Documents
3
Period of Report
2026-01-08

Document Format Files

Seq Description Document Type Size
1 6-K ef20062541_6k.htm 6-K 14080
2 EXHIBIT 99.1 ef20062541_ex99-1.htm EX-99.1 26622
3 image00001.jpg GRAPHIC 3191
  Complete submission text file 0001140361-26-000715.txt   46297
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38283 | Film No.: 26519642
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)